VERTEX PHARMACEUTICALS INC / MA (VRTX) reporting calendar
VERTEX PHARMACEUTICALS INC / MA files periodic reports with the SEC as VRTX on Nasdaq. Atlas tracks 24 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 31 Jul 2026 – 10 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 5 May 2026
- Reports on record
- 24
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 36 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open VRTX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 5 May 2026 | 35 days | 0000875320-26-000173 |
| 10-K | 31 Dec 2025 | 13 Feb 2026 | 44 days | 0000875320-26-000056 |
| 10-Q | 30 Sep 2025 | 4 Nov 2025 | 35 days | 0000875320-25-000232 |
| 10-Q | 30 Jun 2025 | 5 Aug 2025 | 36 days | 0000875320-25-000216 |
| 10-Q | 31 Mar 2025 | 6 May 2025 | 36 days | 0000875320-25-000192 |
| 10-K | 31 Dec 2024 | 13 Feb 2025 | 44 days | 0000875320-25-000053 |
| 10-Q | 30 Sep 2024 | 5 Nov 2024 | 36 days | 0000875320-24-000223 |
| 10-Q | 30 Jun 2024 | 2 Aug 2024 | 33 days | 0000875320-24-000198 |
| 10-Q | 31 Mar 2024 | 7 May 2024 | 37 days | 0000875320-24-000139 |
| 10-K | 31 Dec 2023 | 15 Feb 2024 | 46 days | 0000875320-24-000062 |
| 10-Q | 30 Sep 2023 | 7 Nov 2023 | 38 days | 0000875320-23-000031 |
| 10-Q | 30 Jun 2023 | 2 Aug 2023 | 33 days | 0000875320-23-000021 |
| 10-Q | 31 Mar 2023 | 2 May 2023 | 32 days | 0000875320-23-000012 |
| 10-K | 31 Dec 2022 | 10 Feb 2023 | 41 days | 0000875320-23-000007 |
| 10-Q | 30 Sep 2022 | 28 Oct 2022 | 28 days | 0000875320-22-000038 |
| 10-Q | 30 Jun 2022 | 5 Aug 2022 | 36 days | 0000875320-22-000030 |
| 10-Q | 31 Mar 2022 | 6 May 2022 | 36 days | 0000875320-22-000014 |
| 10-K | 31 Dec 2021 | 9 Feb 2022 | 40 days | 0000875320-22-000007 |
| 10-Q | 30 Sep 2021 | 3 Nov 2021 | 34 days | 0000875320-21-000033 |
| 10-Q | 30 Jun 2021 | 30 Jul 2021 | 30 days | 0000875320-21-000027 |
| 10-Q | 31 Mar 2021 | 30 Apr 2021 | 30 days | 0000875320-21-000015 |
| 10-K | 31 Dec 2020 | 11 Feb 2021 | 42 days | 0000875320-21-000006 |
| 10-Q | 30 Sep 2020 | 30 Oct 2020 | 30 days | 0000875320-20-000043 |
| 10-Q | 30 Jun 2020 | 31 Jul 2020 | 31 days | 0000875320-20-000030 |
Source: SEC EDGAR company submissions for CIK 0000875320. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.